Table 1.
Material | SCLC | Adenocarcinoma | Squamous cell carcinoma | NOS | Total LC |
EBUS-TBNA/EUS-FNA of lymph nodes | 250 (27.7%) | 331 (36.7%) | 209 (23.1%) | 114 (12.5%) | 904 (100%) |
EBUS-TBNA/EUS-FNA of tumour | 88 (24.7%) | 94 (25.8%) | 135 (37.2%) | 44 (12.3%) | 361 (100%) |
EBUS-TBNA/EUS-FNA metastases to adrenal gland | 3 (42.9%) | 1 (14.3%) | 2 (28.6%) | 1 (14.3%) | 7 (100%) |
Forceps biopsy of tumour | 156 (22%) | 163 (25%) | 270 (41.5%) | 62 (9.5%) | 651 (100%) |
EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration; EUS-FNA, endoscopic ultrasound-guided fine needle aspiration; LC, lung cancer; NOS, not otherwise specified; SCLC, small cell lung cancer.